What Happened?
, -based Nkarta Therapeutics Promoted Rachel Rice as Associate General Counsel, IP
About the Company
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.
About the Person
Rachel Rice is Associate General Counsel, IP at Nkarta Therapeutics. Previously, Rachel held various senior legal leadership roles in the industry.
Info Source
News
Short Profile